Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Palivizumab, when given through the veins or into a muscle (systemically), reduces hospitalisations due to respiratory syncytial virus (RSV) and reduces respiratory problems later on (chest wheezing), ...

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial virus prophylaxis, with uptake varying by race and other social factors.

Respiratory syncytial virus (RSV) is a common germ that can settle into your lungs and airways. It's the top cause of upper respiratory infection in babies and toddlers, but anyone can get it.

RSV (respiratory syncytial virus) is a virus that infects the lungs and breathing passages. It is one of the major remaining infectious diseases for which there is currently no vaccine or specific ...

RSV can lead to a severe lung infection called bronchiolitis, which is dangerous in babies and can result in them being ...

A vaccine in the Respiratory Syncytial Virus Infection pipeline presents a cost-effective solution to reducing the burden of RSV, as current options for both prevention and treatment are limited ...

New research has suggested that vaccination of pregnant women has been linked to a drop in newborns being admitted to ...

Thousands of premature babies in the UK can now be protected against a common winter virus which can cause a dangerous lung ...

With Canada’s colder weather comes respiratory virus season, as flus and respiratory syncytial virus (RSV) circulate alongside COVID-19.While Canadians learned a lot about how to protect ...

French pharmaceutical company Sanofi said it is acquiring London-based Vicebio to expand its range of respiratory virus ...